Chemoinformaics analysis of N-VALERIC ACID
Molecular Weight | 102.133 | nRot | 3 |
Heavy Atom Molecular Weight | 92.053 | nRig | 1 |
Exact Molecular Weight | 102.068 | nRing | 0 |
Solubility: LogS | -0.623 | nHRing | 0 |
Solubility: LogP | 1.354 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 16.6219 |
nHD | 1 | BPOL | 10.9001 |
QED | 0.582 |
Synth | 1.486 |
Natural Product Likeliness | 0.563 |
NR-PPAR-gamma | 0.444 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.005 |
Pgp-sub | 0.004 |
HIA | 0.01 |
CACO-2 | -4.754 |
MDCK | 0.0000888 |
BBB | 0.88 |
PPB | 0.574294 |
VDSS | 0.244 |
FU | 0.50916 |
CYP1A2-inh | 0.036 |
CYP1A2-sub | 0.315 |
CYP2c19-inh | 0.026 |
CYP2c19-sub | 0.238 |
CYP2c9-inh | 0.008 |
CYP2c9-sub | 0.936 |
CYP2d6-inh | 0.013 |
CYP2d6-sub | 0.224 |
CYP3a4-inh | 0.008 |
CYP3a4-sub | 0.046 |
CL | 6.537 |
T12 | 0.803 |
hERG | 0.011 |
Ames | 0.009 |
ROA | 0.117 |
SkinSen | 0.186 |
Carcinogencity | 0.178 |
EI | 0.991 |
Respiratory | 0.073 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.939276 |